Literature DB >> 16933477

Practical applications of topical therapy for allergic, infectious, and seborrheic disorders.

Wayne Rosenkrantz1.   

Abstract

Topical therapy is extremely important in the management of allergic, infectious, and seborrheic disorders. It can be used as a sole therapy or adjunctive therapy for these disorders, often minimizing the need for systemic therapy. In allergic diseases, pruritus can be decreased by removing allergen, desensitizing the skin or other antipruritic effects. Many agents can also maintain or replace moisture to the skin and have emollient effects. When used for infectious conditions, topical therapy can decrease microbial counts and reduce surface colonization of microbes and help to prevent relapses. Antiseborrheic products function by normalizing keratinocyte turnover rates by reducing epidermal division (keratoplastic), normalizing keratinization, and increasing desquamation (keratolytic). There are many different topical vehicles and modes of application: shampoos, whirlpools, soaks, rinses, sprays, lotions, gels, creams, and ointments. Shampoos are often the most practical and effective. The practitioner needs to become familiar with many active ingredients to learn what products are indicated for specific diseases.

Entities:  

Mesh:

Year:  2006        PMID: 16933477     DOI: 10.1053/j.ctsap.2006.05.003

Source DB:  PubMed          Journal:  Clin Tech Small Anim Pract        ISSN: 1096-2867


  2 in total

1.  Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitis.

Authors:  Santiago Cerrato; Pilar Brazis; Maria Federica Della Valle; Alda Miolo; Anna Puigdemont
Journal:  BMC Vet Res       Date:  2012-11-26       Impact factor: 2.741

2.  A pilot study of the in vitro antimicrobial activity and in vivo residual activity of chlorhexidine and acetic acid/boric acid impregnated cleansing wipes.

Authors:  Rebecca Rafferty; Victoria H Robinson; Jennifer Harris; Sally A Argyle; Tim J Nuttall
Journal:  BMC Vet Res       Date:  2019-10-30       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.